Patents by Inventor Melinda Marie PETERS

Melinda Marie PETERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug-induced activation of the Reelin signaling system
    Patent number: 11629127
    Abstract: Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.
    Type: Grant
    Filed: April 18, 2022
    Date of Patent: April 18, 2023
    Assignee: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Edwin John Weeber, Qingyou Li, Melinda Marie Peters, Hana Marie Soueidan
  • DRUG-INDUCED ACTIVATION OF THE REELIN SIGNALING SYSTEM
    Publication number: 20220324805
    Abstract: Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER 2 or VLDLR.
    Type: Application
    Filed: April 18, 2022
    Publication date: October 13, 2022
    Inventors: Edwin John Weeber, Qingyou Li, Melinda Marie Peters, Hana Marie Soueidan
  • Drug-induced activation of the Reelin signaling system
    Patent number: 11306059
    Abstract: Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders. Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: April 19, 2022
    Assignee: University of South Florida
    Inventors: Edwin John Weeber, Qingyou Li, Melinda Marie Peters, Hana Marie Soueidan
  • DRUG-INDUCED ACTIVATION OF THE REELIN SIGNALING SYSTEM
    Publication number: 20200347018
    Abstract: Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders. Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.
    Type: Application
    Filed: October 25, 2018
    Publication date: November 5, 2020
    Inventors: Edwin John WEEBER, Qingyou LI, Melinda Marie PETERS, Hana Marie SOUEIDAN